Medical; Abortion, Fetus
14
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Gemeprost Versus Dinoprostone in First Trimester Miscarriages
Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone
Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination
Home Follow-up After Medication Abortion
Effectiveness of Pretreatment Letrozole Versus Misoprostol Alone in Missed Abortion
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso
Fertility and Obstetric Outcomes After Medical Management Versus Surgical Treatment for First-trimester Miscarriage First-trimester Miscarriage
Uterocervical Angle in the Pregnancy Termination of Multiparous Women
Simplified Medical Abortion Screening: A Pilot Demonstration Project
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
Comparison of Telephone Follow-up With In-person Follow-up After Medical Abortion
Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Termination of Pregnancy Analgesia
Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation
Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and Uzbekistan